Cargando…

Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension

OBJECTIVE—: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation through reactive oxygen species (ROS), influencing the development of pulmonary arterial hypertension (PAH). We hypothesize that in PASMCs, serotonin induces oxidative stress through NADPH-oxidase–deriv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hood, Katie Y., Mair, Kirsty M., Harvey, Adam P., Montezano, Augusto C., Touyz, Rhian M., MacLean, Margaret R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Basic Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478178/ https://www.ncbi.nlm.nih.gov/pubmed/28473438 http://dx.doi.org/10.1161/ATVBAHA.116.308929

Ejemplares similares

Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension
por: Hood, Katie Y., et al.
Publicado: (2016)

Vascular Biology of Superoxide-Generating NADPH Oxidase 5—Implications in Hypertension and Cardiovascular Disease
por: Touyz, Rhian M., et al.
Publicado: (2019)

Notch3 signalling and vascular remodelling in pulmonary arterial hypertension
por: Morris, Hannah E., et al.
Publicado: (2019)

Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways
por: Morris, Hannah E., et al.
Publicado: (2023)

Vascular biology of ageing—Implications in hypertension
por: Harvey, Adam, et al.
Publicado: (2015)

Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis
por: Harvey, Adam P., et al.
Publicado: (2017)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

NADPH oxidase-1 deficiency offers little protection in Salmonella typhimurium-induced typhlitis in mice
por: Chu, Fong-Fong, et al.
Publicado: (2016)

ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease
por: Kuriakose, Jithin, et al.
Publicado: (2021)

Shear and Integrin Outside-In Signaling Activate NADPH-Oxidase 2 to Promote Platelet Activation
por: Xu, Zheng, et al.
Publicado: (2021)

The Anorexigenic Effect of Serotonin Is Mediated by the Generation of NADPH Oxidase-Dependent ROS
por: Fang, Xin-Ling, et al.
Publicado: (2013)

NADPH Oxidase 5 Is a Pro‐Contractile Nox Isoform and a Point of Cross‐Talk for Calcium and Redox Signaling‐Implications in Vascular Function
por: Montezano, Augusto C., et al.
Publicado: (2018)

Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
por: Harvey, Adam, et al.
Publicado: (2016)

Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2019)

NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice
por: Langbein, Heike, et al.
Publicado: (2016)

NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis
por: Vara, Dina, et al.
Publicado: (2020)

Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2020)

The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series)
por: MacLean, Margaret (Mandy) R.
Publicado: (2018)

Redox signaling, Nox5 and vascular remodeling in hypertension
por: Montezano, Augusto C., et al.
Publicado: (2015)

NADPH Oxidase and Neurodegeneration
por: Hernandes, Marina S, et al.
Publicado: (2012)

Sex steroids receptors, hypertension, and vascular ageing
por: Connelly, Paul J., et al.
Publicado: (2021)

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)–Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells
por: Harrison, Craig B., et al.
Publicado: (2020)

Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase
por: Jia, Ji, et al.
Publicado: (2014)

Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension
por: Dempsie, Yvonne, et al.
Publicado: (2013)

Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females
por: Dempsie, Yvonne, et al.
Publicado: (2011)

NADPH Oxidases and Their Role in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

NADPH Oxidases in Pain Processing
por: Kallenborn-Gerhardt, Wiebke, et al.
Publicado: (2022)

NADPH Oxidases in Aortic Aneurysms
por: Salmon, Morgan
Publicado: (2022)

Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells
por: Alves-Lopes, Rheure, et al.
Publicado: (2023)

Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2)
por: Kuntic, Marin, et al.
Publicado: (2020)

TRPM7, Magnesium, and Signaling
por: Zou, Zhi-Guo, et al.
Publicado: (2019)

Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
por: Neves, Karla B., et al.
Publicado: (2023)

HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase
por: Nanduri, Jayasri, et al.
Publicado: (2015)

Natural Compounds as Modulators of NADPH Oxidases
por: Maraldi, Tullia
Publicado: (2013)

NADPH Oxidases and Mitochondria in Vascular Senescence
por: Salazar, Gloria
Publicado: (2018)

NADPH oxidases: Current aspects and tools
por: Schröder, Katrin
Publicado: (2020)

Architecture of the NADPH oxidase family of enzymes
por: Ogboo, Blessing C., et al.
Publicado: (2022)

(Poly)phenols and the regulation of NADPH oxidases
por: Fraga, Cesar G., et al.
Publicado: (2023)

NOX5: Molecular biology and pathophysiology
por: Touyz, Rhian M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hdtpcd5qnh58jdhbb0bejpcfc